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Introduction 
According to the World Health Organization 
(WHO) report, colorectal cancer is the fourth most 
common form of cancer globally and the third 
leading cause of deaths among all cancers, 
accounting for 639,000 deaths worldwide per year.1
Resveratrol is a promising candidate in prevention 
and treatment of colon cancer that has recently 
been well documented.2-5  With respect to 
prevention or treatment of colon cancer by orally 
administered resveratrol, i.e. release of resveratrol 
in the colonic region at specific amount, maximal 
biological effect can be achieved.6 Designing 
colon-targeted resveratrol delivery system can 
increase resveratrol bioavailability at target site and 
reduce the administered dose and systemic side 
effects.6 Pectin has been used to formulate colon 
specific delivery because of resistance to the 
enzymes present in the stomach and intestine and 
complete degradation by the colonic bacterial 
enzymes.7-9 Pectin can be administered to humans 
without any limits of daily intake.10 However, high 
swelling behavior of pectin and lack of 
reproducible performance of pectin formulations 
are two important challenges in the efficiency of 
pectin-based system and require more 
modification.11 Formation of polyelectrolyte 
complex between pectin as an anionic biopolymer 
A B S T R A C T 
Background: Resveratrol effects on the prevention and treatment of colon 
cancer have been well documented recently, but low solubility, rapid 
absorption and metabolism of resveratrol limit its beneficial effects on colon 
cancer. Designing a formulation that enhances the solubility of resveratrol, 
protects resveratrol from oxidation and isomerization, and delivers it to the 
colon is a priority of food and drug industry. In this study, resveratrol-
polyethylene glycol (PEG)-loaded pectin-chitosan polyelectrolyte complex 
was designed as a colon targeted delivery system.  
Methods: The effects of adding PEG, ultra-sonication time, pH, and pectin to 
chitosan ratio were investigated on particle size, polydispersity index (PDI), 
zeta potential by particle size analyzer, and scanning electron microscopy 
(SEM). Encapsulation efficiency (EE), release of resveratrol in simulated 
gastrointestinal fluid, and different pHs were analyzed via High Performance 
Liquid Chromatography (HPLC). Antioxidant activity was measured by (2, 2-
diphenyl-1-picryl-hydrazyl-hydrate) DPPH free-radical method. 
Results: Results showed that colloidal stable micro-particles (725 ± 20 nm) 
with PDI < 0.3 and zeta potential +27 ± 2 mV was formed in the ratio of 5:1 
of pectin to chitosan w/v % after a 10-min sonication. Encapsulation 
efficiency was 81 ± 7 %. The reduction of antioxidant activity of resveratrol 
loaded micro-particles after one month was less than 13%. Micro-particles 
released about 33% of resveratrol in the simulated gastric and intestinal fluids.  
Conclusion: Two-thirds of the loaded resveratrol in Pectin-Chitosan complex 
reached colon. The developed system had enough specification for enriching 
fruit based drinks due to remarkable colloidal stability in the pH range of 3.5 
to 4.5. 
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and chitosan as oppositely charged biopolymer 
enhances the water resistance of the resultant pectin 
complexes to some degree and overcomes the 
pectin high solubility in the small intestine.12,13 
Chitosan has favorable biological properties, such 
as non-toxicity, biodegradability, tissue-adhesive 
activity, and anti-inflammatory response and offers 
excellent matrix for pH responsive drug release.14 
Most of reported pectin-chitosan complexes for 
colon specific delivery were in the form of visible 
bead or capsule which were not suitable for food 
and beverages.15-20 The main concern of future food 
industry is enriching food and beverages with  
bioactive components in natural matrix for specific 
purpose.21 Therefore, development of micro- or 
nano-particles as colloidal suspension is a priority. 
The purpose of the present study was to 
characterize physicochemical properties, colloidal 
stability, and release behavior of resveratrol-
polyethylene glycol(PEG)-loaded delivery system 
based on the complex of pectin-chitosan using 
particle size analyzer, zeta potential, HPLC, 
antioxidant activity, and SEM experiments. Thus, 
in this study, a resveratrol-loaded composite of 
pectin and chitosan was developed to design a food 
grade colon targeted colloidal delivery system. 
 
Materials and Methods 
Materials 
Preparation of stock solution 
Pectin stock solution (1.66 % w/v) was prepared by 
placing pectin in sterile bi-distilled water and 
agitated over night until complete hydration. 
Thereafter, it was centrifuged at 7000 rpm for 20 
min and filtered with 0.45 µm syringe filter 
(cellulose acetate). The degree of esterification 
(DE) of pectin was determined according to 
Bocheket al. using titration method.22 Chitosan 
stock solution 1% w/v was prepared in 1% v/v 
acetic acid glacial and agitated over night until 
complete hydration, and then, it was diluted to 
lower concentration and centrifuged at 12000 rpm 
for 30 min and filtered with 0.22 µm syringe filter 
(cellulose acetate). The molecular weight was 
assayed by laser light scattering (Zetasizer ZS, 
Malvern instruments, UK). The pH was measured 
at room temperature (25°C) with pH meter 
(Metrohm, Germany). The pH of the pectin and 
chitosan solution was found to be ~3.6±0.1 and 
~4.2±0.1, respectively. 
Formulation of delivery system 
Polyelectrolyte complexation was formed between 
two oppositely charge bio polymers at different 
concentration ratios.16,23 One milliliter of 
resveratrol solution in PEG (5 mM) was added to 9 
mL pectin solution (1.66% w/v) under stirring at 
500 rpm (Heidolph, Germany). After two hours 
stirring, the samples were sonicated for 0, 5, 10 and 
15 min by probe sonicator (Hielscher, Germany) 
with a power of 200 W. Energy input was provided 
by a H3 sonotrode containing a piezoelectric 
crystal with a titanium probe of 3 mm in diameter. 
The amplitude of oscillation was set at 70 microns. 
All experiments were performed at room 
temperature, and the solution was stored in the 
refrigerator. The combination of pectin and 
resveratrol was added to chitosan solution in ratios 
of 1:1, 3:1, 5:1, and 10:1. It is worth noting that 
pectin concentration in all formulations was 
adjusted at 0.75 % w/v, and concentrations of the 
chitosan were 0.75%, 0.25, 0.15%, 0.075 % w/v.  
 
Antioxidant activity 
The potential antioxidant activity of delivery 
system was measured by the free radical 
scavenging effect on 2, 2- Diphenyl-1-
picrylhydrazyl (DPPH) radicals; this method is 
based on the reduction of DPPH in an alcoholic 
solution in the presence of a hydrogen-donating 
antioxidant.24 In its radical form, DPPH absorbsat 
517 nm, but upon reduction by an antioxidant or a 
radical species, its absorption decreases.24,25 
Radical scavenging activity of resveratrol solution 
in polyethylene glycol and pectin-chitosan complex 
in the presence and absence of resveratrol were 
measured according to Helal et al.26 In order to 
release resveratrol from delivery system and 
measure antioxidant activity, pectinase enzyme (0.6 
mg/mL) was added to the samples.27 Then, the 
samples were shaken and incubated at 25 ºC in a 
dark chamber for 30 min. The absorption of the 
samples was measured at 517 nm with a 
spectrophotometer (Pharmacia Biotech, England). 
A decrease 
in absorbance of the DPPH solution indicates 
increased DPPH radical scavenging activity. The 
values were calculated according to the following 
formula:26 
 
Scavenging effect (% ) =
Blank absorbance− Sample absorbance
Blank absorbance
 × 100             Eq.(1) 
 
Scanning electron microscopy 
The morphology and structure of samples were 
visualized using scanning electron-microscope 
(SEM).To perform scanning electron microscopy, 
freeze dried samples was mounted on aluminum 
stubs. This was then gold coated in vacuum by a 
sputter. Samples were observed (KYKY-EM3200, 
Beijing, China) microscope. Photographs was taken 
at excitation voltage of 26 KV. 
Encapsulation efficiency 
Encapsulation efficiency (EE) of resveratrol in 
pectin-chitosan complex particles was assessed 
using Amicon centrifugal filter (Millipore, MW cut 
off 100,000Da).28 The resveratrol loaded particles 
were placed on the upper compartment of 
Amicon® tubes and centrifuged at 4000 rpm for 30 
 44 | Pharmaceutical Sciences, March 2017, 23, 42-49 
Colon,  Delivery, Resveratrol 
  
 
 
min to separate free resveratrol from the lower 
compartment of Amicon according to Pandita et al. 
with some modifications.29 A volume of 500 µL of 
filtrated solution was removed and mixed with 500 
µl ethanol. A volume of 50 µL of mixture was 
injected into HPLC-UV:30 
 
EE (%) =
Total resveratrol−Free resveratrol
Total resveratrol
 × 100  Eq.(2) 
 
Release behavior at different pH values 
Release behavior was assayed in four different pH 
values by incubating 1 mL of selected formulation 
inside the dialysis bag suspended in 20 mL of 
acetate buffer. The pH was adjusted at pH 2.5, pH 
3.5, pH 4.5 and pH 5.5 by 0.1 M acetic acid in one 
month at 4°C. Released resveratrol from delivery 
system was measured in sequence7 days and the 
same volume of fresh incubation medium was 
replaced after every sampling. 
 
Release behavior at simulated gastrointestinal 
fluid 
Cumulative release of resveratrol from micro-
particles was evaluated by dialysis bag diffusion 
technique (cut off value =11000 Da) by mimicking 
oral delivery to colon specific site. The particles’ 
transit condition was set as gastric condition (pH 
1.2 for 2 h for stomach), intestinal condition (pH 
6.8 for 3 h small intestine), and colon (pH 7.4 for 2 
h) in presence and absence of pectinase.31 To 
mimic stomach condition without enzymes under 
sink condition, 1mL of sample containing 
resveratrol was added into the dialysis bag and 
suspended in 20 mL of HCl (0.1 M)-ethanol w/v 
(80:20 ratio). Thereafter, dialysis bag was 
suspended in 20 mL phosphate buffer-ethanol 
(ratio 80:20) to mimic small intestine condition. 
For simulated colon condition, the buffer was 
changed (pH 7.4) in the presence and absence of 
0.6 mg/mL pectinase enzyme under stirrer in an 
incubator (50 rpm, 37°C) (shaker incubator, 
Heidolph unimax 1010, Germany). Resveratrol 
content was assessed at the end of simulation. 
 
Statistical analysis 
All the experiments were performed three times 
independently with triplicates and the results were 
expressed as mean ± standard deviation. Statistical 
analysis was carried out using Graph Pad Prism 
software to find the statistical significance of these 
values. A probability of p < 0.05 was considered to 
be statistically significant. 
 
Results 
Pectin-chitosan (P/C) complex 
The degree of esterification (DE) of pectin was 
determined 70 ± 2 % w/v, and the average 
molecular weight was around 120 kDa. To increase 
resveratrol solubility, PEG (4 kDa) solution was 
used. Resveratrol was easily dissolved in PEG to 
concentration of 1.64 M in preliminary 
experiments. As shown in Figure 1, adding PEG to 
pectin solution and the ultra-sonication for 10 min 
had a significant effect on particle size reduction. 
 
 
Figure 1. Effect of ultra-sonication time on particle size 
(A), PDI (B), Zeta potential (C), 200W, amplitude 70%. 
 
PEG increased viscosity of media and cavitation 
intensity during ultra-sonication.32 Zeta potential of 
ultra-sonicated pectin solution increased from -15 
mV to about -30 mV. Particle size decreased from 
1220 to 760 nm. The PDI was in acceptable range 
after 10 min sonication (PDI<0.3). Then, this 
formula was selected to form the polyelectrolyte 
complex with chitosan. According to Figure 2, by 
increasing the concentrations of chitosan from 
0.075 to 0.75%w/v, at constant pectin 
concentration (0.75% w/v), the zeta potential 
increased from -3 ± 0.7 mV (P/C, 10:1 %w/v) to 
+43 ± 1.8 mV (P/C, 1:1 %w/v), and consequently, 
the particle size decreased from 861 ± 42 to 622 ± 
21 nm. The pH of samples was set at 4.5±0.1. 
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Micro-particles formed on 1:1, 3:1, and 5:1 P/C 
ratios were stable but complex on 10:1 P/C ratio 
was unstable during storage time, which may be 
related to lower electrostatic repulsion. 
Homogenous particles with appropriate PDI were 
achieved at 5:1 P/C (particle size 725 ± 20 nm and 
zeta potential +27 ± 2 mV, pH=4.5 ± 0.1). 
Therefore, this formulation was selected for 
resveratrol loading due to fewer changes in their 
size and PDI during 30 days storage at 4ºC. Figure 
3 (A) shows the SEM image and morphology of 
micro-particles that verify the measured size using 
DLS. 
Encapsulation efficiency 
As shown in Figure 4, EE of pectin: chitosan 
micro-particles at 10:1 were significantly lower 
than other formulations. The EE of micro-particles 
on 5:1, 3:1, and 1:1 ratios was more than 80% and 
wasn’t significantly different. Thus, due to 
homogenous size distribution of complex in the 
ratio of 5:1, it was chosen as an appropriate 
formulation for encapsulation of resveratrol. 
 
 
 
 
 
Figure 2. Effect of different pectin: chitosan ratio on particle size (A), PDI (B), Zeta potential (C) in first day and after thirty days. 
 
 
 
Figure 3. SEM image (A), Particle size (B), Zeta potential of resveratrol- PEG loaded pectin-chitosan particles (pectin: chitosan, 
5:1). 
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Table1. Cumulative release of resveratrol at different pH values during one month (%). 
Cumulative release at different pH values 
pH 
Day       2.5 3.5 4.5 5.5 
2th         0.33±0.03a 0.29±0.02a 0.14±0.03b 0.51±0.03c 
8th          7.37±0.49a 5.63±0.37b 4.24±0.25c 14.20±1.21d 
15th           11.47±1.48a 9.56±0.60a 7.35±0.70b 20.41±2.32c 
22th          17.06±1.53a 12.42±0.93b 9.48±0.91c 26.34±2.94 d 
29th          21.04±2.02a 18.91±1.41a 13.74±1.32b 44.75±3.53c 
Different words indicate significant difference at the 5% level in Duncan’s test. 
 
 
Figure 4. Encapsulation efficiency of different formulations 
after preparation. 
 
Release behavior at different pH values 
In order to evaluate the stability of the system at 
different pH values (2.5, 3.5, 4.5, and 5.5), the 
release behavior of resveratrol was assessed by 
HPLC during one month with seven days interval 
at 4 °C (Table1). Obviously, no initial burst release 
of resveratrol was observed in different pH 
values.The resveratrol released in pH 4.5 was lower 
than other pHs during storage (13.74 ± 1.32%), and 
the maximum amount of release was determined at 
pH 5.5 with 44.75 ± 3.53% at the end of the one-
month period. 
 
Release behavior in simulated gastrointestinal 
fluid 
The amount of released resveratrol in simulated 
gastric and small intestinal condition was 5 ± 0.5% 
(pH=1.2 in absence of enzymes) and 16 ± 0.8 % 
(pH=6.8), respectively. The cumulative release of 
resveratrol before reaching the large intestine was 
around 21%. Furthermore, at pH=7.4 and in 
absence of pectinase, the resveratrol release was 22 
± 1.8 %. Indeed, cumulative release of resveratrol 
in absence of pectinase was about 43%, while in 
presence of pectinase at pH=7.4, the entire 
resveratrol was released. 
 
Antioxidant activity  
Figure 5 shows that the antioxidant activity of 
pectin-chitosan complex without resveratrol was 37 
± 5 %, which is mainly attributed to the presence of 
chitosan. Antioxidant activity of encapsulated 
resveratrol was 93 ± 6 % in comparison to the pure 
form of resveratrol (72 ± 3.5%). Antioxidant 
activities of free resveratrol and encapsulated form 
were measured after 30 days storage at 4º C. The 
results indicated that the antioxidant activity of 
encapsulated form decreased 13 ± 2 % whereas the 
reduction of free resveratrol was 48 ± 4%. 
 
 
Figure 5. Antioxidant activity of Pectin-Chitosan complex 
without resveratrol (a), pure form of resveratrol (b) 
encapsulated resveratrol (c) in the same concentration of 
resveratrol (5 Mm). 
 
Discussion 
Pectin-chitosan (P/C) complex 
Polyelectrolyte complex of pectin and chitosan was 
stabilized via attractive force between carboxyl 
groups of pectin and amine groups of chitosan.13 
The pKa value of chitosan was 6.3; hence, in the 
2.0–5.0 pH range, most of chitosan amine groups 
were protonated.33 In contrast, the degree of 
ionization of pectin decreased with decreasing pH 
values (pKa= 3.6). Therefore the presence of 
optimum mole of repeating units of pectin and 
chitosan is a critical control point in formulation of 
a colloidal stable suspension with compact 
structure; for example, much larger amounts of 
pectin were required to interact with chitosan at 
low pH values.13,34 Based on the results, stable 
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colloidal suspension with appropriate PDI was 
achieved in the P/C ratio of 5:1 (particle size 725 ± 
20 nm and zeta potential      +27 ±2 mV, pH=4.5 ± 
0.1). It was shown in previous studies that polymer 
concentration, addition order, mass ratio, and pH 
solution had important influences on the formation 
of polyelectrolyte complex and particles 
characteristics.35-37 High electrostatic repulsion 
between particles suggests a structure whose 
surface is dominated by chitosan.37 
 
Encapsulation efficiency 
The low solubility and loading capacity are two 
critical limitations in designing delivery system for 
resveratrol.15 Thus, the current formulated micro-
particles could adjust the loaded resveratrol for 
achieving the defined amount of resveratrol for 
colon because of high solubility of resveratrol in 
PEG.  It was reported that the EE of progesterone 
loaded pectin-zinc-chitosan in the concentrations of 
1, 4, 4, and 1 % w/v was around 75 % with the size 
of 500-700 µm.20 EE of albumin in pectin-chitosan 
complex was around 58-73%.38 
 
Release behavior at different pH values 
Low water solubility of resveratrol induced to 
cumulative release in different pH values (2.5, 3.5, 
and 4.5) had no significant difference during 30 
days storage.  
The pH of pectin-chitosan complex influences the 
charge density of system and release behavior of 
resveratrol.15  The release of resveratrol from 
micro-particles at pH 4.5 was lower than other pH 
values during 30 days (13.7 ±1.3%). It would be 
related to the fact that pectin is fully charged at pHs 
above 3.5. Therefore, at pHs 4-5, stronger complex 
is formed, also the highest release at pH 5.5 is 
probably related to this fact that as the pH increases 
toward 6.0, amine group of chitosan is 
deprotonated;  therefore, some complex is 
decomposed.23 
 
Release behavior in simulated gastrointestinal 
fluid 
The results of presence study are almost in 
agreement with recent studies and the release of 
encapsulant in upper pHs is more than lower pHs. 
Das et al.reported that pectin-zinc-chitosan micro-
particles released approximately 4.5 %, 40 %, and 
95 % of loaded resveratrol during transition from 
simulated gastric, intestinal, and colonic fluids, 
respectively.15 In another study, < 25 % of loaded 
resveratrol in zinc pectinate beads was released in 
pH 1.5 after 2 hours, and almost 50% of the loaded 
resveratrol was released in pH 6.3 after 3 hours.16 
In present study in presence of pectinase at pH=7.4, 
the entire resveratrol was released, indicating that 
once the complex reaches the colon, it is 
decomposed by microbial pectinase, and the entire 
encapsulant is released from the complex structure. 
 
Antioxidant activity  
In presence of chitosan, antioxidant activity of 
encapsulated resveratrol was significantly more 
than pure form of resveratrol, indicating synergetic 
antioxidant effects of resveratrol with chitosan.39 In 
addition, the reduction of antioxidant activity of 
encapsulated resveratrol was significantly lower 
than free resveratrol after one month. This is in line 
with previous studies in which encapsulation 
prevented the reduction of antioxidant activity by 
time.25 
 
Conclusion 
This study was conducted to develop a delivery 
system based on pectin and chitosan containing 
resveratrol. PEG enhanced the solubility of 
resveratrol and reduced the average particle size. 
Ultra-sonication of pectin enhanced zeta potential. 
The resultant micro-particles of pectin-chitosan had 
smaller particles with suitable PDI at 5:1 (pH=4.5). 
Release behavior of resveratrol in simulated 
gastrointestinal fluids showed that more than two 
thirds of the loaded resveratrol reached colon, more 
than the minimum amounts (50 μM) of resveratrol 
for showing its therapeutic effects. It seems that the 
developed system has enough specification for 
enriching fruit based drinks due to remarkable 
colloidal stability in the pH range of 3.5 to 4.5. 
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